export interface StateContent {
  slug: string;
  name: string;
  fullName: string;
  population: string;
  obesityRate: string;
  adultObesityCount: string;
  teleHealthLaw: string;
  insuranceLandscape: string;
  majorCities: string[];
  localContext: string;
  metaTitle: string;
  metaDescription: string;
}

export const stateContent: StateContent[] = [
  {
    slug: "texas",
    name: "Texas",
    fullName: "Texas",
    population: "30.5 million",
    obesityRate: "37.4% (CDC 2023)",
    adultObesityCount: "~8.1 million adults",
    teleHealthLaw:
      "Texas follows federal telehealth standards. The Texas Medical Board allows prescribing via telehealth after an appropriate clinical evaluation. No in-person visit is required for GLP-1 prescriptions via telehealth.",
    insuranceLandscape:
      "Texas has one of the lowest rates of employer-sponsored GLP-1 coverage for weight management. Most Medicaid plans (excluding those with specific obesity benefits) do not cover weight management medications.",
    majorCities: ["Houston", "Dallas", "San Antonio", "Austin", "Fort Worth"],
    localContext:
      "Texas consistently ranks among the states with the highest obesity prevalence in the nation. The problem is especially acute in Houston — the fourth-largest city in the US — and throughout South Texas, where rates of obesity-related conditions like type 2 diabetes and cardiovascular disease exceed national averages. A combination of factors drive this: food deserts in lower-income neighborhoods, car-dependent sprawl limiting physical activity, and a disproportionately large population working shift or gig economy jobs with limited time for healthcare.\n\nAccess to GLP-1 medications has historically been difficult for most Texas residents. With one of the highest uninsured rates in the country — over 18% of adults lack coverage — and employers who typically don't sponsor weight management drug benefits, the list price of brand-name options like Wegovy ($1,349/mo) or Ozempic ($935/mo) is simply out of reach for most people. Even among the insured, prior authorization requirements and frequent coverage denials create months-long delays for patients who do qualify.\n\nTelehealth changes the access equation dramatically for Texas residents. Rather than waiting weeks for an in-person obesity medicine appointment — a specialty with limited geographic coverage outside of Dallas, Houston, and Austin — patients across Texas can complete an evaluation and, if eligible, receive compounded semaglutide starting at $279/month with free 2-day shipping anywhere in the state. From El Paso to Beaumont, from the Panhandle to the Rio Grande Valley, telehealth-delivered GLP-1 therapy is now a practical option for the millions of Texans for whom brand-name medications remain financially impossible.",
    metaTitle: "GLP-1 Weight Loss Medication in Texas | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide and tirzepatide prescribed online by licensed providers for Texas residents. Same active ingredient as Ozempic — 79% less than retail. Free 2-day shipping to all Texas cities.",
  },
  {
    slug: "california",
    name: "California",
    fullName: "California",
    population: "39.5 million",
    obesityRate: "27.3% (CDC 2023)",
    adultObesityCount: "~8.7 million adults",
    teleHealthLaw:
      "California has among the most progressive telehealth laws in the US. SB 1238 (2016) and subsequent legislation established telehealth parity. GLP-1 prescriptions are routinely issued via telehealth after clinical evaluation.",
    insuranceLandscape:
      "California's large employer base includes tech companies that often cover GLP-1 medications. California Medi-Cal covers some weight management services. Several Blue Shield and Kaiser plans now include Wegovy coverage under employer-negotiated benefits.",
    majorCities: ["Los Angeles", "San Diego", "San Francisco", "San Jose", "Sacramento"],
    localContext:
      "California's obesity rate sits below the national average, but with nearly 40 million residents, that still translates to roughly 8.7 million adults living with obesity — a larger absolute number than most entire states. And despite the perception of California as health-conscious, the reality is deeply uneven: while coastal urban residents in San Francisco and Santa Monica have strong access to healthcare and relatively better insurance coverage, large swaths of inland California tell a very different story. The Central Valley — stretching from Bakersfield through Fresno and Stockton — has among the highest obesity and diabetes rates in the state, with a predominantly agricultural workforce that faces both insurance gaps and limited specialist availability.\n\nThe cost of living in California creates a GLP-1 affordability paradox. Even with household incomes higher than the national average, the $1,349/month price tag for Wegovy consumes a far larger share of disposable income when rent already tops $3,000/month in major metro areas. Many middle-income Californians — too wealthy for Medi-Cal, but working for employers who haven't added GLP-1 coverage — face a coverage cliff that leaves them paying out of pocket. The Bay Area and LA tech employer trend toward GLP-1 coverage is real, but it primarily benefits workers at large companies with generous benefits; the millions employed by small businesses, in the gig economy, or in healthcare, food service, and education often have no coverage at all.\n\nFor Central Valley residents, rural Northern California communities, and uninsured or underinsured patients throughout the state, telehealth-delivered GLP-1 therapy at compounded pricing represents a genuine access breakthrough. Nature's Journey works with licensed California providers and ships to every ZIP code in the state — so whether you're in Los Angeles, Fresno, Redding, or anywhere in between, a clinical evaluation and prescription can happen entirely online, with medication arriving at your door within two business days.",
    metaTitle: "GLP-1 Weight Loss Treatment in California | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide and tirzepatide available online for California residents. Licensed CA providers, compounded GLP-1 from $279/mo — 79% less than Wegovy. Ships to Los Angeles, San Diego, San Francisco, and all CA ZIP codes.",
  },
  {
    slug: "florida",
    name: "Florida",
    fullName: "Florida",
    population: "22.6 million",
    obesityRate: "34.5% (CDC 2023)",
    adultObesityCount: "~5.4 million adults",
    teleHealthLaw:
      "Florida enacted comprehensive telehealth legislation in 2019 (HB 23). Licensed Florida providers can prescribe via telehealth with a proper clinical evaluation. No in-person requirement for GLP-1 therapy.",
    insuranceLandscape:
      "Florida's large retiree population faces particular challenges — Medicare Part D historically has not covered anti-obesity medications (though this is being contested). Private employers in Florida have mixed coverage, with hospitality and service sector jobs rarely offering GLP-1 benefits.",
    majorCities: ["Miami", "Orlando", "Tampa", "Jacksonville", "Fort Lauderdale"],
    localContext:
      "Florida's large and growing retiree population faces a structural problem with GLP-1 access: Medicare Part D, which covers most prescription drugs for seniors, has historically excluded anti-obesity medications from coverage. For the millions of Floridians over 65 who are on Medicare as their primary insurance, this creates a categorical coverage gap — they may have excellent drug coverage for other conditions but pay 100% out-of-pocket for weight management medications. Compounded semaglutide at $279/month can make a medically meaningful treatment financially viable for fixed-income retirees who would otherwise simply go without.\n\nFlorida's economy is heavily weighted toward hospitality, tourism, and service industries — sectors with notoriously poor employer-sponsored benefits. Disney World, cruise line workers, hotel and restaurant staff, and the vast non-union service workforce that supports Florida's $100B+ tourism economy typically don't have employer coverage for weight management medications. For these workers — many of whom are in their 30s and 40s and at the highest risk for developing obesity-related complications — the $1,349/month brand-name price is simply not a realistic option. The financial gap between brand and compounded options is particularly consequential in this demographic.\n\nSouth Florida's unique demographic composition — with large Cuban-American, Haitian, and Caribbean communities in Miami-Dade and Broward counties — creates additional healthcare access complexity. Cultural factors, language barriers, and distrust of the traditional healthcare system can make in-person obesity medicine visits particularly difficult to access. Telehealth, which allows patients to complete evaluations privately from home and communicate with providers asynchronously, removes many of these barriers. Nature's Journey ships free 2-day to all Florida addresses, from Pensacola to Key West.",
    metaTitle: "GLP-1 Weight Loss in Florida | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Florida residents — same active ingredient as Ozempic and Wegovy, 79% less. Licensed FL providers, free 2-day shipping to Miami, Orlando, Tampa, and all FL ZIP codes.",
  },
  {
    slug: "new-york",
    name: "New York",
    fullName: "New York",
    population: "20.2 million",
    obesityRate: "28.5% (CDC 2023)",
    adultObesityCount: "~4.4 million adults",
    teleHealthLaw:
      "New York State Department of Health supports telehealth prescribing. The New York State Telehealth Act provides broad authorization. Prescribing GLP-1 medications via telehealth is routine after appropriate clinical evaluation.",
    insuranceLandscape:
      "New York has relatively progressive insurance mandates. Some NYSHIP (state employee) plans now cover anti-obesity medications. The NYC market has many large employer plans with GLP-1 coverage, though coverage is far from universal for small business employees and the self-insured.",
    majorCities: ["New York City", "Buffalo", "Rochester", "Albany", "Syracuse"],
    localContext:
      "New York City's extreme cost of living creates a healthcare affordability paradox. Despite higher average incomes, New Yorkers face some of the highest healthcare out-of-pocket costs in the nation. For the millions of New Yorkers employed by small businesses, working in the gig economy, or simply priced out of comprehensive insurance plans, the $1,349/month price of brand-name Wegovy represents nearly two months of rent in some outer-borough neighborhoods. Even among patients with insurance, coverage gaps, high deductibles, and prior authorization requirements mean that many effectively pay out of pocket — at which point the gap between $1,349/mo brand and $279/mo compounded becomes the decisive factor.\n\nUpstate New York presents a different but equally significant access challenge. In cities like Buffalo, Rochester, Syracuse, and the rural communities stretching between them, obesity medicine specialists are scarce. Primary care physicians in these areas are stretched thin, and wait times for in-person obesity consultations can stretch to months. For patients dealing with obesity-related health conditions who need to start treatment now, the traditional in-person healthcare pathway is simply too slow. Telehealth eliminates the geographic and scheduling barriers, connecting upstate patients to licensed New York providers who can evaluate, prescribe, and support them from anywhere in the state.\n\nNew York's employer landscape does skew toward better GLP-1 coverage compared to most states — large employers in finance, media, tech, and healthcare often include weight management drug benefits. But this leaves millions of New Yorkers — small business employees, freelancers, hospitality and service workers, and the self-employed — without coverage. For these patients, Nature's Journey's compounded semaglutide program at $279/month offers the same active ingredient as brand-name medications at a fraction of the cost, delivered to any New York address in two business days.",
    metaTitle: "GLP-1 Weight Loss in New York | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for New York residents. Same active ingredient as Ozempic — 79% less than retail price. Licensed NY providers, free 2-day shipping to NYC, Buffalo, Rochester, and all NY ZIP codes.",
  },
  {
    slug: "pennsylvania",
    name: "Pennsylvania",
    fullName: "Pennsylvania",
    population: "13.0 million",
    obesityRate: "34.0% (CDC 2023)",
    adultObesityCount: "~3.4 million adults",
    teleHealthLaw:
      "Pennsylvania telehealth legislation (Act 45 of 2020) established a robust framework. GLP-1 medications can be prescribed via telehealth after a clinical evaluation without requiring an in-person visit.",
    insuranceLandscape:
      "Pennsylvania has a significant manufacturing and healthcare employer base. Many PA Blue Cross/Blue Shield plans have added GLP-1 coverage under pressure from large employers. Medicaid (MA) coverage for obesity medications is limited.",
    majorCities: ["Philadelphia", "Pittsburgh", "Allentown", "Erie", "Reading"],
    localContext:
      "Pennsylvania's industrial heartland communities — the former steel and mining towns of western PA, the coal regions of central Pennsylvania, the manufacturing corridors of the Lehigh Valley — have some of the highest obesity rates in the state. Decades of deindustrialization have left many of these communities with higher poverty rates, reduced access to fresh food, and healthcare systems that are stretched thin. The demographic profile of working-class Pennsylvania — men and women who spent careers in physically demanding but now-diminished industries — faces elevated risk for obesity-related conditions including type 2 diabetes, cardiovascular disease, and joint damage.\n\nPhiladelphia and Pittsburgh present contrasting GLP-1 access landscapes. In Philadelphia, the uninsured rate is higher, poverty is more concentrated, and the gap between those with excellent employer coverage and those paying out of pocket is stark. In Pittsburgh, the large healthcare and university employer base means more residents have access to employer-sponsored GLP-1 coverage — but even there, coverage is far from universal. Rural Pennsylvania — the vast swath of the state between the two major metros — faces genuine access challenges, with specialist providers concentrated in urban centers and primary care practices spread thin across dozens of smaller communities.\n\nThe union healthcare dynamic is particularly relevant in Pennsylvania. UAW, USW, UFCW, and other union contracts have increasingly included language requiring GLP-1 coverage for weight management — creating meaningful access for unionized workers. But the non-union portion of Pennsylvania's workforce, which includes retail, restaurant, logistics, and gig economy workers, often has no comparable coverage. For these Pennsylvanians, Nature's Journey's compounded semaglutide program at $279/month delivers the same clinical treatment as brand-name medications, prescribed by licensed Pennsylvania providers, with free 2-day shipping anywhere in the state.",
    metaTitle: "GLP-1 Weight Loss in Pennsylvania | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Pennsylvania residents. Licensed PA providers, compounded GLP-1 from $279/mo — 79% less than Wegovy. Free 2-day shipping to Philadelphia, Pittsburgh, Allentown, and all PA ZIP codes.",
  },
  {
    slug: "illinois",
    name: "Illinois",
    fullName: "Illinois",
    population: "12.8 million",
    obesityRate: "33.8% (CDC 2023)",
    adultObesityCount: "~3.3 million adults",
    teleHealthLaw:
      "Illinois enacted comprehensive telehealth reform. The Telehealth Act (Public Act 100-0527) established parity requirements. GLP-1 prescriptions via telehealth are fully authorized after appropriate clinical evaluation.",
    insuranceLandscape:
      "Illinois has some of the strongest insurance parity laws in the US. Several large Illinois-based employers (including major healthcare systems) cover GLP-1 medications. Illinois Medicaid (Medicaid/CHIP) has limited weight management drug coverage.",
    majorCities: ["Chicago", "Aurora", "Rockford", "Joliet", "Naperville"],
    localContext:
      "Chicago's food environment and community health landscape tell two very different stories depending on which neighborhood you're in. On the North Shore and in affluent Lincoln Park or River North, access to premium food options, health clubs, and specialist providers is excellent. But on Chicago's South and West Sides — communities like Englewood, Austin, and Roseland — food deserts, limited healthcare infrastructure, and higher rates of poverty create conditions where obesity and its complications are far more prevalent. These same South and West Side communities have faced decades of hospital closures and reduced specialist availability, making even basic obesity care difficult to access locally.\n\nIllinois's progressive insurance parity laws are a genuine advantage for many residents — the state has been more aggressive than most in requiring insurers to cover weight management services. Several large Chicago-area employers, including major healthcare systems and financial institutions, have added GLP-1 coverage in recent years. But Illinois Medicaid's limited coverage for obesity medications means that the lowest-income Illinoisans — the population with the highest rates of obesity and the least access to specialist care — are often left out of the coverage improvements that have benefited commercially insured patients.\n\nThe suburban versus rural Illinois divide is also significant. Collar counties around Chicago — DuPage, Lake, Will, Kane — have healthcare infrastructure roughly comparable to national urban standards. But central and southern Illinois, including cities like Rockford, Peoria, and Springfield, as well as the rural communities between them, face access challenges that mirror those in other rural Midwest states. For these patients, telehealth-delivered GLP-1 care removes the geographic barriers to treatment. Nature's Journey ships to all Illinois ZIP codes with free 2-day delivery, connecting Chicago residents and rural downstate patients alike to licensed providers and compounded semaglutide starting at $279/month.",
    metaTitle: "GLP-1 Weight Loss in Illinois | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Illinois residents. Licensed IL providers, compounded GLP-1 from $279/mo. Free 2-day shipping to Chicago, Rockford, Joliet, and all Illinois ZIP codes.",
  },
  {
    slug: "ohio",
    name: "Ohio",
    fullName: "Ohio",
    population: "11.8 million",
    obesityRate: "37.1% (CDC 2023)",
    adultObesityCount: "~3.4 million adults",
    teleHealthLaw:
      "Ohio has authorized telehealth prescribing under Ohio Revised Code Chapter 4731. The Ohio Medical Board explicitly permits GLP-1 prescriptions via telehealth after clinical evaluation.",
    insuranceLandscape:
      "Ohio is home to several major self-insured employers (automotive, steel, healthcare) with mixed GLP-1 coverage policies. Ohio Medicaid has not added obesity medication coverage. The Ohio market has high out-of-pocket cost exposure.",
    majorCities: ["Columbus", "Cleveland", "Cincinnati", "Toledo", "Akron"],
    localContext:
      "Ohio's obesity rates are among the highest in the Midwest, and the geographic distribution of the problem reflects the state's economic history. Appalachian Ohio — the southeastern quarter of the state including counties like Athens, Meigs, Vinton, and Morgan — has some of the highest obesity, poverty, and poor health outcome rates in the entire country. These communities, many of which were built around coal mining and manufacturing that have long since declined, face compounding health challenges: limited access to fresh food, high rates of food insecurity, and healthcare infrastructure that has been hollowed out over decades. Specialist access in these areas is genuinely scarce — the nearest obesity medicine physician may be an hour or more away.\n\nThe automotive and manufacturing workforce is central to Ohio's demographic story. In the Cleveland-Akron corridor, Toledo, Dayton, and the smaller manufacturing towns throughout the state, union contracts through UAW and USW have historically provided better healthcare coverage than non-union employers — but GLP-1 coverage under these plans has been inconsistent. Many autoworkers and former autoworkers are in exactly the age demographic (45-65) where obesity-related health complications are most impactful and where GLP-1 therapy has shown the strongest clinical benefit. Columbus, as a growing tech and healthcare hub, presents a somewhat different picture — with better employer coverage and specialist access — but even there, patients without employer GLP-1 coverage face the full retail price burden.\n\nOhio Medicaid's lack of coverage for obesity medications is a significant gap. With Medicaid serving roughly 3 million Ohioans, the absence of obesity drug coverage leaves a large portion of the state's most economically vulnerable population without access to a clinically proven treatment. For these patients, and for all Ohio residents paying out of pocket, compounded semaglutide at $279/month with telehealth delivery represents a fundamentally different access equation. Nature's Journey's licensed Ohio providers can evaluate and prescribe remotely, with medication shipped free in 2 days to any Ohio address.",
    metaTitle: "GLP-1 Weight Loss in Ohio | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Ohio residents. Licensed OH providers, compounded GLP-1 from $279/mo — 79% less than brand price. Free 2-day shipping to Columbus, Cleveland, Cincinnati, and all OH ZIP codes.",
  },
  {
    slug: "georgia",
    name: "Georgia",
    fullName: "Georgia",
    population: "11.0 million",
    obesityRate: "36.4% (CDC 2023)",
    adultObesityCount: "~2.9 million adults",
    teleHealthLaw:
      "Georgia passed comprehensive telehealth legislation (HB 307, 2019). Licensed Georgia providers can prescribe via telehealth after an appropriate evaluation. No restrictions specific to GLP-1 medications.",
    insuranceLandscape:
      "Georgia has not expanded Medicaid, creating a significant coverage gap. Large Atlanta-area employers (tech, finance, media) vary on GLP-1 coverage. Rural Georgia has particularly high uninsured rates and poor specialist access.",
    majorCities: ["Atlanta", "Augusta", "Columbus", "Macon", "Savannah"],
    localContext:
      "Georgia's obesity crisis is geographically concentrated but demographically broad. The Black Belt region of southwest and south-central Georgia — counties like Terrell, Quitman, Clay, and Webster — has some of the highest combined rates of obesity, poverty, and poor health outcomes in the United States. These rural communities, many with majority Black populations and deep historical roots in agricultural labor, face a convergence of food access challenges, generational health disparities, and healthcare infrastructure deficits that have made meaningful obesity treatment effectively inaccessible for decades. A single county in rural south Georgia may have no obesity medicine specialist within 60 miles.\n\nAtlanta's economic boom of the past two decades has created a two-tier health access reality. Tech companies, financial institutions, media firms, and healthcare systems concentrated in the Buckhead, Midtown, and Perimeter corridors offer employees relatively competitive benefits — and some have begun covering GLP-1 medications under employer-negotiated plans. But Atlanta's economic success has not distributed evenly. Large portions of the metro area's workforce — in warehousing and logistics, food service, retail, and the growing gig economy — work for employers who don't offer GLP-1 coverage. And for many residents in historically underserved Atlanta neighborhoods, healthcare distrust and transportation barriers make in-person specialist visits impractical regardless of coverage.\n\nGeorgia's decision not to expand Medicaid has left an estimated 300,000+ adults in a coverage gap — earning too much for traditional Medicaid but too little to access marketplace coverage effectively. This population, disproportionately concentrated in rural Georgia and in lower-income urban communities, is also disproportionately affected by obesity and its complications. For Georgians across this spectrum — from rural communities to Atlanta's outer suburbs — telehealth-delivered GLP-1 care at compounded pricing is often the only financially realistic option. Nature's Journey ships free 2-day to all Georgia addresses, from Atlanta to Savannah to the smallest rural counties.",
    metaTitle: "GLP-1 Weight Loss in Georgia | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Georgia residents. Licensed GA providers, compounded GLP-1 from $279/mo. Free 2-day shipping to Atlanta, Augusta, Savannah, and all Georgia ZIP codes.",
  },
  {
    slug: "north-carolina",
    name: "North Carolina",
    fullName: "North Carolina",
    population: "10.7 million",
    obesityRate: "35.7% (CDC 2023)",
    adultObesityCount: "~2.8 million adults",
    teleHealthLaw:
      "North Carolina Medical Board supports telehealth prescribing. The NC Telehealth Act and subsequent NCGS 90-18.2 establish clear authorization for prescribing via telehealth including GLP-1 medications.",
    insuranceLandscape:
      "North Carolina expanded Medicaid in December 2023. NC Medicaid currently covers some obesity-related services. The Research Triangle and Charlotte areas have large tech and finance employers with better coverage. Rural NC has high uninsured rates.",
    majorCities: ["Charlotte", "Raleigh", "Greensboro", "Durham", "Winston-Salem"],
    localContext:
      "North Carolina is experiencing one of the most dramatic urban-rural divergences in the country. The Charlotte metro area, the Research Triangle (Raleigh-Durham-Chapel Hill), and to a lesser extent Greensboro-Winston-Salem, have seen explosive economic growth driven by tech, finance, healthcare, and life sciences. Workers at major Research Triangle employers — SAS, Biogen, Lenovo, and dozens of biotech and pharma companies — are increasingly likely to have GLP-1 coverage in their employer plans. Charlotte's financial sector (Bank of America, Truist, Wells Fargo regional operations) similarly offers competitive benefits. For this portion of NC's workforce, insurance access to GLP-1 treatment is improving meaningfully.\n\nBut North Carolina's rapidly growing cities exist alongside persistently rural communities in the eastern coastal plain, the Piedmont interior, and the western mountains that tell a very different story. Eastern North Carolina — counties like Bladen, Columbus, Robeson, and Hoke — have obesity rates well above the state average, higher poverty rates, and specialist healthcare access that trails urban areas by a wide margin. These communities, which include large Native American (Lumbee) and Black populations, have historically faced compounding barriers to healthcare including transportation, cultural trust, and insurance coverage. North Carolina's December 2023 Medicaid expansion was a significant development for coverage access, but the expansion's limitations for obesity medications mean that many newly covered Medicaid patients still cannot access GLP-1 therapy through their insurance.\n\nFor the millions of North Carolinians in the coverage gap — including rural residents, small business employees, and those who newly gained Medicaid but still face medication coverage limits — telehealth-delivered GLP-1 care at compounded pricing represents meaningful access. Nature's Journey's licensed North Carolina providers can evaluate patients statewide, and medication ships free in 2 days to any NC address — from Charlotte to the Outer Banks, from the Triangle to the mountains of Cherokee County.",
    metaTitle: "GLP-1 Weight Loss in North Carolina | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for North Carolina residents. Licensed NC providers, compounded GLP-1 from $279/mo. Free 2-day shipping to Charlotte, Raleigh, Durham, and all NC ZIP codes.",
  },
  {
    slug: "michigan",
    name: "Michigan",
    fullName: "Michigan",
    population: "10.0 million",
    obesityRate: "36.9% (CDC 2023)",
    adultObesityCount: "~2.9 million adults",
    teleHealthLaw:
      "Michigan enacted telehealth legislation in 2020 (PA 359). GLP-1 medications can be prescribed via telehealth in Michigan after appropriate clinical evaluation.",
    insuranceLandscape:
      "Michigan has a strong union healthcare tradition — UAW contracts and state employee plans have better drug coverage than average. Michigan Medicaid (Healthy Michigan Plan) has expanded but doesn't broadly cover obesity medications.",
    majorCities: ["Detroit", "Grand Rapids", "Warren", "Sterling Heights", "Lansing"],
    localContext:
      "Michigan's obesity burden is geographically concentrated in two distinct corridors. The Detroit metropolitan area — including the city itself as well as Flint, Saginaw, Pontiac, and the surrounding communities — carries very high rates of obesity, diabetes, and related conditions against a backdrop of economic stress, healthcare infrastructure challenges, and decades of disinvestment. Detroit's population includes a large percentage of residents on Medicaid, Medicare, or without insurance, and the city's primary care capacity is stretched to meet basic healthcare needs let alone specialty obesity medicine. Flint and Saginaw, still recovering from industrial decline and in Flint's case the water crisis, face similar dynamics with even fewer healthcare resources.\n\nMichigan's UAW heritage creates a distinctive healthcare dynamic for autoworkers and their families. UAW contracts — particularly those covering General Motors, Ford, and Stellantis employees — have historically included strong pharmaceutical coverage, and recent contract negotiations have brought GLP-1 medications into scope for many active workers. This is a meaningful development for the large segment of Michigan's workforce employed in automotive and auto supply industries. However, retirees on Medicare, laid-off workers, and the growing non-union portion of Michigan's workforce — particularly in tech, retail, and service — face coverage gaps that make out-of-pocket GLP-1 costs prohibitive.\n\nMichigan's Upper Peninsula and the rural northern Lower Peninsula present a genuine access frontier. The UP — geographically vast, sparsely populated, with very limited specialist provider availability — has among the highest obesity rates in the state combined with among the lowest access to obesity medicine expertise. Telehealth was already becoming more important for UP healthcare delivery before the pandemic, and post-pandemic infrastructure improvements have made reliable internet access more widely available. Nature's Journey can serve patients throughout Michigan, from metro Detroit to the Keweenaw Peninsula, with licensed providers, free 2-day shipping, and compounded semaglutide starting at $279/month.",
    metaTitle: "GLP-1 Weight Loss in Michigan | From $279/mo | Nature's Journey",
    metaDescription:
      "Semaglutide prescribed online for Michigan residents. Licensed MI providers, compounded GLP-1 from $279/mo — 79% less than retail. Free 2-day shipping to Detroit, Grand Rapids, Lansing, and all Michigan ZIP codes.",
  },
];
